EurekAlert! Cancer Research - News Releases

News Releases

Updates every hour. Last Updated: 29-Nov-2025 12:11 ET (29-Nov-2025 17:11 GMT/UTC)

‘Fiery’ cell death during bladder cancer treatment may trigger chemo resistance by fueling cancer stem cells

Houston Methodist
Peer-Reviewed Publication

Chemotherapy used to target and kill bladder cancer cells may trigger an inflammatory response that ultimately may make the cancer more resistant to treatment, according to new research from scientists at Houston Methodist.

Journal: Science Advances
Funder: NIH/National Cancer Institute, Cancer Prevention and Research Institute of Texas

Inflammation triples depression risk for older adults with insomnia

University of California - Los Angeles Health Sciences
Peer-Reviewed Publication

Chronic inflammation, already tied to heart disease and cancer, may also worsen the emotional toll of poor sleep. A new UCLA Health study found that older adults with insomnia who experience inflammatory exposure face triple the risk of developing depressive symptoms compared to sound sleepers.

Journal: JAMA Psychiatry

Living near St. Louis-area Coldwater Creek during childhood linked with higher risk of cancer from radiation

Harvard T.H. Chan School of Public Health
Peer-Reviewed Publication

Living near Coldwater Creek—a Missouri River tributary north of St. Louis that was polluted by nuclear waste from the development of the first atomic bomb—in childhood in the 1940s, ’50s, and ’60s was associated with an elevated risk of cancer, according to a new study led by Harvard T.H. Chan School of Public Health. The researchers say the findings corroborate health concerns long held by community members.

Journal: JAMA Network Open
Funder: NIH/National Institutes of Health

How to more efficiently study complex treatment interactions

Massachusetts Institute of Technology
Reports and Proceedings

A new experimental design framework could enable scientists to efficiently estimate how combinations of interventions will affect a group of cells, reducing the cost of experiments and providing less biased data that could be used to understand disease mechanisms or develop new treatments.

Funder: Advanced Undergraduate Research Opportunities Program at MIT, Apple, National Institutes of Health, Office of Naval Research, DOE/US Department of Energy, Eric and Wendy Schmidt Center at the Broad Institute, Simons Investigator Award

Stephenson Global Scholar Grants Program awards $5.3 million to drive breakthroughs in pancreatic cancer research

City of Hope
Grant and Award Announcement

The Stephenson Global Pancreatic Cancer Research Institute and its partner City of Hope, one of the country’s largest and most advanced cancer research and treatment organizations, today announced the six inaugural recipients of the prestigious Stephenson Scholar Grants, awarding $5.25 million to support high-impact research aimed at transforming the understanding, early detection and treatment of pancreatic cancer.

OHSU scientists develop tool that improves tissue cancer analysis

Oregon Health & Science University
Peer-Reviewed Publication

Developed by researchers at Oregon Health & Science University’s Knight Cancer Institute, the tool, dubbed OmicsTweezer, uses advanced machine learning techniques to analyze biological data at a scale large enough to estimate the composition of cell types in a sample of tissue that may be taken from a biopsy. This process allows scientists to map the cellular makeup of tumors and surrounding tissues — an area known as the tumor microenvironment.

Journal: Cell Genomics
Funder: NIH/National Institute of General Medical Sciences, NIH/National Cancer Institute, NIH/National Cancer Institute, U.S. Department of Defense, Prostate Cancer Data Science Award

New antibody selectively targets immune cells that suppress anti-tumor responses

Impact Journals LLC
Peer-Reviewed Publication

BUFFALO, NY – July 16, 2025 – A new research paper was published in Volume 16 of Oncotarget on July 9, 2025, titled “A novel anti-human CD25 mAb with preferential reactivity to activated T regulatory cells depletes them from the tumor microenvironment.”

Journal: Oncotarget

University of Houston engineer leads team advancing early detection of ovarian cancer

University of Houston
Grant and Award Announcement

With a $1.2 million grant from the Department of Defense, a University of Houston engineer will lead a team of researchers in finding early markers for ovarian cancer.

The Germans Trias Research Institute and ICO Badalona describe genomic alterations that may help predict treatment response in an aggressive type of breast cancer

Germans Trias i Pujol Research Institute
Peer-Reviewed Publication

Researchers at IGTP, HUGTiP and ICO Badalona have identified genetic alterations, including frequent TP53 mutations, that could serve as biomarkers to guide treatment decisions in HER2-positive breast cancer.

Journal: Modern Pathology

Giving T cells a break: controlled physical barrier created to boost cancer immunotherapy

Chinese Academy of Sciences Headquarters
Peer-Reviewed Publication

Prof. LIANG Xingjie's team from the National Center for Nanoscience and Technology, along with Prof. GONG Ningqiang from the University of Science and Technology of China, has developed a biomimetic physical barrier (BPB) that temporarily blocks T cell–tumor cell interactions, thereby delaying T cell exhaustion and enabling a stronger, more sustained immune response.

Journal: Proceedings of the National Academy of Sciences